Towards Biology-Informed Risk-Stratified Therapy in Bone Sarcomas

Thursday, September 24, 2026, 8:00 AM - 9:00 AM, Marlo Thomas Center Auditorium, Memphis, TN

Presented by David Shulman, MD Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Instructor of Pediatrics, Harvard Medical School. Hosted by Sara Federico MD Member, St. Jude Faculty/Director, Division of Solid Tumor with the Department of Oncology.

This session will be held in person in the Marlo Thomas Center Auditorium; a Webex link will also be available. 

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

-----

The St. Jude Children’s Research Hospital Department of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 1.00 CPE hours (0.1 CEU per 1 CPE hour).

Pharmacy continuing education credit will be available to all participants who attend, text attendance, and complete a program assessment and evaluation. Credits will be uploaded and viewable on-line at www.napb.net within approximately two weeks following the date of the presentation.  Participants should contact the CPE staff if credit does not appear within 4 weeks of a program.

 

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

The faculty for this activity are listed below. Click to view the faculty member's financial disclosure information and bio. 

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Thursday, September 24, 2026